| Net Cash Provided by (Used in) Operating Activities |
$395,865 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$525,787 |
USD |
-120% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$634,806 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
900,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,015,042 |
shares |
0.05% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$764,728 |
USD |
-798% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,111,490 |
USD |
-30% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$3,078,109 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$10,467,062 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Depreciation |
$2,561,437 |
USD |
5.4% |
Q1 2024 |
Q1 2024 |
| Deferred Income Tax Expense (Benefit) |
$42,673 |
USD |
49% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$97,885,123 |
USD |
0.05% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$42,280 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$19,783,654 |
USD |
22% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |